128 related articles for article (PubMed ID: 33590779)
1. A Marine Carotenoid of Fucoxanthinol Accelerates the Growth of Human Pancreatic Cancer PANC-1 Cells.
Terasaki M; Takahashi S; Nishimura R; Kubota A; Kojima H; Ohta T; Hamada J; Kuramitsu Y; Maeda H; Miyashita K; Takahashi M; Mutoh M
Nutr Cancer; 2022; 74(1):357-371. PubMed ID: 33590779
[TBL] [Abstract][Full Text] [Related]
2. A Fucoxanthinol Induces Apoptosis in a Pancreatic Intraepithelial Neoplasia Cell.
Terasaki M; Inoue T; Murase W; Kubota A; Kojima H; Kojoma M; Ohta T; Maeda H; Miyashita K; Mutoh M; Takahashi M
Cancer Genomics Proteomics; 2021; 18(2):133-146. PubMed ID: 33608310
[TBL] [Abstract][Full Text] [Related]
3. Effects of CLIC4 on Fucoxanthinol-Induced Apoptosis in Human Colorectal Cancer Cells.
Yokoyama R; Kojima H; Takai R; Ohta T; Maeda H; Miyashita K; Mutoh M; Terasaki M
Nutr Cancer; 2021; 73(5):889-898. PubMed ID: 33703973
[TBL] [Abstract][Full Text] [Related]
4. Requirement of CLIC4 Expression in Human Colorectal Cancer Cells for Sensitivity to Growth Inhibition by Fucoxanthinol.
Yokoyama R; Kushibiki A; Yamada S; Kubota A; Kojima H; Ohta T; Hamada J; Maeda H; Mutoh M; Terasaki M
Cancer Genomics Proteomics; 2022; 19(4):428-444. PubMed ID: 35732323
[TBL] [Abstract][Full Text] [Related]
5. Effect of Fucoxanthinol on Pancreatic Ductal Adenocarcinoma Cells from an
Terasaki M; Nishizaka Y; Murase W; Kubota A; Kojima H; Kojoma M; Tanaka T; Maeda H; Miyashita K; Mutoh M; Takahashi M
Cancer Genomics Proteomics; 2021; 18(3 Suppl):407-423. PubMed ID: 33994364
[TBL] [Abstract][Full Text] [Related]
6. Fucoxanthin and its deacetylated product, fucoxanthinol, induce apoptosis of primary effusion lymphomas.
Yamamoto K; Ishikawa C; Katano H; Yasumoto T; Mori N
Cancer Lett; 2011 Jan; 300(2):225-34. PubMed ID: 21078541
[TBL] [Abstract][Full Text] [Related]
7. Dual Biological Functions of a Cytoprotective Effect and Apoptosis Induction by Bioavailable Marine Carotenoid Fucoxanthinol through Modulation of the Nrf2 Activation in RAW264.7 Macrophage Cells.
Taira J; Sonamoto M; Uehara M
Mar Drugs; 2017 Oct; 15(10):. PubMed ID: 28984834
[TBL] [Abstract][Full Text] [Related]
8. Glycine and succinic acid are effective indicators of the suppression of epithelial-mesenchymal transition by fucoxanthinol in colorectal cancer stem-like cells.
Terasaki M; Mima M; Kudoh S; Endo T; Maeda H; Hamada J; Osada K; Miyashita K; Mutoh M
Oncol Rep; 2018 Jul; 40(1):414-424. PubMed ID: 29693702
[TBL] [Abstract][Full Text] [Related]
9. Anti-neoplastic effects of fucoxanthin and its deacetylated product, fucoxanthinol, on Burkitt's and Hodgkin's lymphoma cells.
Tafuku S; Ishikawa C; Yasumoto T; Mori N
Oncol Rep; 2012 Oct; 28(4):1512-8. PubMed ID: 22859062
[TBL] [Abstract][Full Text] [Related]
10. Fucoxanthin potentiates anoikis in colon mucosa and prevents carcinogenesis in AOM/DSS model mice.
Terasaki M; Iida T; Kikuchi F; Tamura K; Endo T; Kuramitsu Y; Tanaka T; Maeda H; Miyashita K; Mutoh M
J Nutr Biochem; 2019 Feb; 64():198-205. PubMed ID: 30530259
[TBL] [Abstract][Full Text] [Related]
11. Glycine Is a Predictor for a Suppressive Effect of Fucoxanthinol on Colonosphere Formation Under Hypoxia.
Terasaki M; Ogawa Y; Endo T; Maeda H; Hamada J; Osada K; Miyashita K; Mutoh M
Anticancer Res; 2018 Apr; 38(4):2169-2179. PubMed ID: 29599336
[TBL] [Abstract][Full Text] [Related]
12. Fucoxanthin Inhibits Development of Sigmoid Colorectal Cancer in a PDX Model With Alterations of Growth, Adhesion, and Cell Cycle Signals.
Terasaki M; Tsuruoka K; Tanaka T; Maeda H; Shibata M; Miyashita K; Kanemitsu Y; Sekine S; Takahashi M; Yagishita S; Hamada A
Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):686-705. PubMed ID: 38035706
[TBL] [Abstract][Full Text] [Related]
13. Fucoxanthinol, Metabolite of Fucoxanthin, Improves Obesity-Induced Inflammation in Adipocyte Cells.
Maeda H; Kanno S; Kodate M; Hosokawa M; Miyashita K
Mar Drugs; 2015 Aug; 13(8):4799-813. PubMed ID: 26248075
[TBL] [Abstract][Full Text] [Related]
14. Induction of Anoikis in Human Colorectal Cancer Cells by Fucoxanthinol.
Terasaki M; Maeda H; Miyashita K; Mutoh M
Nutr Cancer; 2017 Oct; 69(7):1043-1052. PubMed ID: 28990814
[TBL] [Abstract][Full Text] [Related]
15. Anti-Inflammatory Effects of Fucoxanthinol in LPS-Induced RAW264.7 Cells through the NAAA-PEA Pathway.
Jin W; Yang L; Yi Z; Fang H; Chen W; Hong Z; Zhang Y; Zhang G; Li L
Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32326173
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of NF-kappaB transcriptional activity enhances fucoxanthinol-induced apoptosis in colorectal cancer cells.
Tamura S; Narita T; Fujii G; Miyamoto S; Hamoya T; Kurokawa Y; Takahashi M; Miki K; Matsuzawa Y; Komiya M; Terasaki M; Yano T; Mutoh M
Genes Environ; 2019; 41():1. PubMed ID: 30693059
[TBL] [Abstract][Full Text] [Related]
17. Fucoxanthinol attenuates oxidative stress-induced atrophy and loss in myotubes and reduces the triacylglycerol content in mature adipocytes.
Yoshikawa M; Hosokawa M; Miyashita K; Fujita T; Nishino H; Hashimoto T
Mol Biol Rep; 2020 Apr; 47(4):2703-2711. PubMed ID: 32180086
[TBL] [Abstract][Full Text] [Related]
18. Fucoxanthin and Its Metabolite Fucoxanthinol in Cancer Prevention and Treatment.
Martin LJ
Mar Drugs; 2015 Jul; 13(8):4784-98. PubMed ID: 26264004
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of mutagenicity of fucoxanthin (FX) and its metabolite fucoxanthinol (FXOH).
Beppu F; Niwano Y; Sato E; Kohno M; Tsukui T; Hosokawa M; Miyashita K
J Toxicol Sci; 2009 Dec; 34(6):693-8. PubMed ID: 19952505
[TBL] [Abstract][Full Text] [Related]
20. Suppressive effects of the marine carotenoids, fucoxanthin and fucoxanthinol on triglyceride absorption in lymph duct-cannulated rats.
Matsumoto M; Hosokawa M; Matsukawa N; Hagio M; Shinoki A; Nishimukai M; Miyashita K; Yajima T; Hara H
Eur J Nutr; 2010 Jun; 49(4):243-9. PubMed ID: 19888619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]